Natural killer cells: from basic research to treatments.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 3342003)

Published in Front Immunol on June 03, 2011

Authors

Eric Vivier1, Sophie Ugolini

Author Affiliations

1: Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée UM 631 Marseille, France. vivier@ciml.univ-mrs.fr

Associated clinical trials:

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection | NCT02346617

Articles cited by this

NK cell recognition. Annu Rev Immunol (2005) 14.40

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04

Functions of natural killer cells. Nat Immunol (2008) 9.88

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature (1986) 9.73

Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68

Adaptive immune features of natural killer cells. Nature (2009) 8.46

"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61

Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature (2005) 7.18

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07

MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 6.98

Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73

Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61

T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol (2006) 6.23

Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 5.91

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity (2008) 5.35

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood (2005) 4.64

Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol (2010) 4.34

Natural killer cell signaling pathways. Science (2004) 4.00

Self-tolerance of natural killer cells. Nat Rev Immunol (2006) 3.75

Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74

Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol (2002) 3.45

Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature (1991) 3.36

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33

Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol (2007) 3.33

Immune functions encoded by the natural killer gene complex. Nat Rev Immunol (2003) 3.21

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17

Natural-killer cells and dendritic cells: "l'union fait la force". Blood (2005) 3.10

Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J (2003) 3.06

Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol (2005) 2.77

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood (2009) 2.75

Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol (2008) 2.70

'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol (2010) 2.57

Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol (2009) 2.44

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity (2007) 2.23

Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol (2004) 2.14

NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol (2009) 2.12

Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med (2010) 2.06

NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol (2009) 2.00

Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J Immunol (2011) 1.97

MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med (2010) 1.95

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90

Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol (2010) 1.83

How do natural killer cells find self to achieve tolerance? Immunity (2006) 1.74

A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol (2005) 1.73

Activation and self-tolerance of natural killer cells. Immunol Rev (2006) 1.46

Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal (2011) 1.30

NK cell response to viral infections in beta 2-microglobulin-deficient mice. J Immunol (1995) 1.30

NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood (2009) 1.29

Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. Proc Natl Acad Sci U S A (2008) 1.20

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A (2009) 1.16

NK cell activating receptors and tumor recognition in humans. Curr Top Microbiol Immunol (2006) 1.00

Immunology: Natural killer cells remember. Nature (2009) 0.83

Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells. J Immunol (1973) 0.78

Articles by these authors

Functions of natural killer cells. Nat Immunol (2008) 9.88

Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68

Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73

TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86

Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol (2012) 3.43

Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A (2005) 2.55

Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A (2011) 2.01

Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science (2012) 1.98

Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med (2007) 1.73

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood (2013) 1.55

Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A (2005) 1.50

Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med (2012) 1.39

Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal (2011) 1.30

Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. J Immunol (2004) 1.26

Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood (2013) 1.19

Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo. Proc Natl Acad Sci U S A (2009) 1.16

CD4+ T cell polarization in mice is modulated by strain-specific major histocompatibility complex-independent differences within dendritic cells. J Exp Med (2003) 1.15

Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol (2004) 1.02

Natural killer cells and malaria. Immunol Rev (2006) 0.98

Tuning the threshold of natural killer cell responses. Curr Opin Immunol (2012) 0.96

Impact of β2 integrin deficiency on mouse natural killer cell development and function. Blood (2011) 0.96

Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells. PLoS One (2007) 0.92

Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response. Cell Host Microbe (2009) 0.90

T cell regulation of natural killer cells. J Exp Med (2013) 0.87

Immunology: Natural killer cells remember. Nature (2009) 0.83

ADAPted secretion of cytokines in NK cells. Nat Immunol (2013) 0.79

[Natural killer cells: adaptation and memory in innate immunity]. Med Sci (Paris) (2013) 0.78

[NK cells and innate immunity to malaria]. Med Sci (Paris) (2006) 0.76